Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05597267 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The MIRIA Acne Scar Study

Study acronym: MIRIA
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fieldsv5
  2. Notable Primary endpoint revisedv4 Show 4 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Primary and study completion dates: Dec 31, 2024 to Feb 28, 2025
    • Secondary endpoints expanded, about 14 words
    • Site details revised at 3 of 3 sites
  3. Notable Primary completion date: Sep 1, 2023 to Dec 31, 2024
    • Study sites: 1 to 3
    • Study completion date: Dec 31, 2023 to Dec 31, 2024
    • Start date changed from estimate of Nov 1, 2022 to Nov 4, 2022
    v3
  4. Minor Re-verified, no change to tracked fieldsv2
  5. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is being conducted to evaluate the performance and efficacy of the AVAVA MIRIA Laser Skin System treatment on acne scars. Participants will be treated with the MIRIA laser at least 4 times with each treatment spaced 4-6 weeks apart. The improvement of acne scars will be evaluated at 1 month and 3 months with a possibility of 6 months evaluation after the fourth treatment.
Trial Details
NCT Number NCT05597267
Lead Sponsor AVAVA, Inc.
Conditions
(from sponsor)
Acne Scars - Mixed Atrophic and Hypertrophic
Related terms Cicatrix, Hypertrophy
Enrollment 75 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov